X
XENE
Xenon Pharmaceut
54.17
+0.05+0.09%After Hours: 54.17 0.00 0.00%17:36 05/22 EDT
OPEN/PREV CLOSE54.16/54.12
TODAY RANGE53.86-55.35
VOL969.84K
MARKET CAP5.24B
52 WEEK RANGE28.19-63.95
AVG VOL (3M)1.41M
% TURNOVER1.00%
TURNOVER--
P/E (TTM)-11.5138
% RANGE2.55%
EPS(TTM)-4.7048
P/E(FORWARD)-11.4042
P/B3.912
BVPS13.85
DIVIDEND--
P/S578.12
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP5.15B
SHARES OUTSTANDING96.67M
NEXT EARNINGS08/10-08/14
FREE FLOAT95.11M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·3d ago
Xenon Pharmaceuticals Signals Strong Momentum In Earnings
Dow Jones·05/12 15:23
Xenon Pharmaceuticals Is Maintained at Overweight by JP Morgan
Dow Jones·05/12 15:23
Xenon Pharmaceuticals Price Target Raised to $80.00/Share From $77.00 by JP Morgan
TipRanks·05/12 12:13
Xenon Pharmaceuticals price target raised to $80 from $77 at JPMorgan
TipRanks·05/11 02:40
Xenon (XENE) Gets a Buy from Stifel Nicolaus
TipRanks·05/10 14:21
Xenon Pharmaceuticals price target raised to $69 from $68 at Wells Fargo
TipRanks·05/10 13:40
Wells Fargo Remains a Buy on Xenon (XENE)
TipRanks·05/09 01:24
Xenon Pharmaceuticals Maps Path After Standout XTOL-2
TipRanks·05/08 22:33
Xenon Pharmaceuticals price target lowered to $78 from $80 at Needham
Dow Jones·05/08 18:25
Xenon Pharmaceuticals Price Target Raised to $82.00/Share From $80.00 by RBC Capital
Dow Jones·05/08 18:25
Xenon Pharmaceuticals Is Maintained at Outperform by RBC Capital
TipRanks·05/08 16:46
Evercore ISI Sticks to Their Buy Rating for Xenon (XENE)
TipRanks·05/08 13:06
Wedbush Reaffirms Their Buy Rating on Xenon (XENE)